<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572020/" ref="ordinalpos=1823&amp;ncbi_uid=4631234&amp;link_uid=PMC3572020" image-link="/pmc/articles/PMC3572020/figure/pone-0056224-g004/" class="imagepopup">Figure 4. LMWF inhibited MAPK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in kidney after IR..  From: Low Molecular Weight Fucoidan against Renal Ischemia-Reperfusion Injury via Inhibition of the MAPK <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Expression levels of ERK, p38, JNK, CREB and c-fos of kidneys after reperfusion for 2 h were detected by Western blot analysis. Representative blotting (left) and quantification of protein levels (right) are shown. Mean ± SEM. n = 3; #P&lt;0.05, ##P&lt;0.01, ###P&lt;0.001 vs. sham, *P&lt;0.05, **P&lt;0.01 vs. saline treated IR group.</div></div>